Introduction
Myelomeningocele is a non-lethal but highly morbid form of neural tube defect (NTD) in which the meninges and neural tissue are exposed to the intrauterine environment. It occurs early, during the formation of the primitive neural tube in the third week of gestation. After gastrulation, the neural plate forms and undergoes extensive folding and fusion to form the neural tube, which is subsequently covered by mesenchyme. Closure of the human neural tube begins in the mid-cervical region and proceeds simultaneously in the cranial and caudal directions. Myelomeningocele occurs when there is a localized failure of neural tube closure. This can occur anywhere along the length of the spinal cord, but it is most common in the lumbar region. The resulting lesion is an open spinal canal with a¯at neural placode instead of a cylindrical spinal cord [1] .
The neurological de®cits sustained by the fetus are postulated to occur in stages, as a`two-hit' hypothesis [2] . In this theory, the ®rst`hit' is the original defect in neurulation that creates the NTD and any associated myelodysplasia, and the second`hit' is the secondary trauma to the spinal cord as a result of its exposure to the intrauterine environment [3] . Fetal surgery for myelomeningocele would theoretically avoid this later injury.
Etiology
The etiology of myelomeningocele is believed to be multifactorial. Exposure to various teratogens including valproic acid, carbamazepine, cytochalasins, calcium antagonists, and hyperthermia have been implicated [4 . . ]. Maternal or fetal de®ciency in folate is also associated with the development of myelomeningocele [5] . Folate supplementation is credited with a 70% decrease in the rate of NTD; however, correlation with maternal serum levels of folate is inconsistent [6 . . ,7 . ]. Genetic factors may also play a role in the development of NTD [8, 9 . ]. Multiple murine models of myelomeningocele exist, and some correlate with speci®c genes that are known to be associated with NTD [10] . For example, the splotch mouse has a naturally occurring defect in the Pax3 gene, resulting in myelomeningocele [11] . In humans, myelomeningocele is associated with chromosomal abnormalities such as trisomy 13 and 18 and with de®ned genetic syndromes such as Waardenburg's syndrome [11] . However, genetic studies have failed to identify any one speci®c gene in humans that can cause myelomeningocele.
Epidemiology
Myelomeningocele affects approximately 0.5±1 per 1000 live births annually, with variations in population and geography. This equates to 1500±2000 affected infants per year in the United States [12] . The personal and societal costs are tremendous, consuming nearly US$200 000 000 annually [13] .
Disability and associated defects
Myelomeningocele leads to neurological injury below the level of the lesion, with paraplegia, urinary and fecal incontinence, sexual dysfunction, and skeletal malformations. There is considerable variation in the neurological outcome associated with the level of the myelomeningocele [14±18]. The potential to walk decreases with more proximal lesions. Many children will experience a deterioration in ambulatory ability as they approach adolescence [19 . . ,20]. This may result from tethering of the spinal cord at the site of the surgical repair or from a decreased strength-to-weight ratio as they grow. The best prognosis for independent walking is with sacral lesions limited to S1 and lower [21] . Lesions above L2 almost always result in wheelchair dependence and scoliosis. Functional impairment with lesions limited to L3±L5 is more dif®cult to predict, but these patients usually need some form of assistance with braces or crutches [22] .
Arnold±Chiari II malformation
All children born with myelomeningocele have the associated Chiari hindbrain malformation, and the vast majority (85±86%) develop hydrocephalus [23, 24] . The Chiari malformation is a pancerebral anomaly, affecting broad areas of the brain. Abnormalities include herniation of the medulla, cerebellar tonsils and vermis through the foramen magnum, a small posterior fossa,`beaking' of the midbrain tectum, enlarged massa intermedia of the thalamus, partial or complete callosal dysgenesis, and structural changes in the skull [25] .
A uni®ed theory regarding the pathogenesis of the Chiari malformation was postulated by McLone and Knepper [26] , who suggested that the open spinal cord and associated free drainage of cerebrospinal¯uid (CSF), promotes collapse of the primitive ventricular system and causes lack of expansion of the rhombencephalic vesicle. This lack of distention leads to a small posterior fossa and subsequent herniation as well as other associated malformations in the brain.
Infants with the Chiari malformation typically develop lower cranial nerve disturbances. These include a weak cry, inspiratory wheezing, prolonged feeding due to poor swallowing, aspiration pneumonia, absent gag re¯ex, apnea, and opisthotonus [27±29]. Some develop spasticity of the upper extremities in childhood and early adolescence, whereas a smaller group develop cerebellar problems including truncal and extremity dysfunction [30] . Respiratory dif®culties and apnea are the most common presentation of Chiari-affected patients, occurring in 45±64% of these patients [31, 32] .
Hydrocephalus
Approximately 85% of patients with thoracolumbar, lumbar, and lumbosacral myelomeningoceles eventually develop hydrocephalus, requiring lifelong CSF decompression to preserve brain and brainstem function, as well as cranial and upper cervical nerve function [33] . The cause of hydrocephalus in myelomeningocele patients is the topic of much debate. Current theories include mechanical obstruction secondary to anatomical changes associated with the Chiari malformation [34] and dysfunctional CSF absorption [28] . Clinically, hydrocephalus may not be present at birth, but may become apparent after closure of the back defect in the ®rst few months of life [35] .
The consequences of hydrocephalus and the Chiari malformation may be dif®cult to separate as they can both cause abnormal pressure on the brainstem, leading to the same symptoms. Myelomeningocele has been associated with a 30% death rate in the ®rst two decades of life, mostly due to respiratory complications [18, 29] . This may be caused either by hydrocephalus or the Chiari malformation or both. The incidence of mental retardation in these patients may be exacerbated by infection, hypoxemia, CSF shunt malfunction, and hydrocephalus; all possible consequences of the Chiari malformation [36 . ,37,38] .
Evidence supporting fetal surgery for myelomeningocele
There are limited data correlating injury to neural tissue and intrauterine exposure. Experiments involving spinal cord culture suggest that late gestation human amniotic uid might be directly toxic to neural tissue [39] . Cultured rat spinal cords were exposed to amniotic¯uid at varying gestational ages. The neurons were largely unaltered early in gestation. However, 34 weeks' gestation amniotic¯uid was highly toxic to the cultured cells. A possible mechanism for this toxicity may be the increased concentration of urea and the decreased tonicity of the¯uid, contributing to a chemical injury to the exposed spinal cord.
Animal experiments
Various methods of intrauterine repair of myelomeningocele have been studied in animal models, including mice, rat, rabbit, sheep, pig, and monkey [40,41,42 . ,43,44] . Methods used for repair include the application of bone paste, skin grafts, and the standard multi-layered closure. The results from these animal experiments have been promising.
In a fetal monkey model, Michejda [44] performed laminectomies in utero, closing one group immediately and leaving the other group open. At birth, the group without repair developed paraplegia and incontinence whereas the group with immediate repair developed normally. In rat models, the surgical creation of spinal dysraphism in midgestation caused deformity and abnormal motor function. The closure of this defect resulted in normal animals at birth [41] . These results were also duplicated by the same group in a pig model [41] . Further evidence of in-utero injury to the exposed spinal cord was demonstrated in surgically created myelomeningocele in fetal sheep. The animals were operated on at 75 days' gestation. One group was assessed before birth and another was assessed at term. The term animals had more severe neurological tissue loss and deranged cytoarchitecture whereas the preterm group had less evidence of such damage [43] .
In other experiments by Meuli and colleagues [45, 46] , surgically created myelomeningoceles were repaired in fetal sheep. Three fetal sheep underwent laminectomy with lumbar spinal cord exposure at 75 days' gestation. At 100 days' gestation, the sheep underwent reoperation with repair using a reversed latissimus dorsi¯ap. At birth, these sheep demonstrated near normal motor function, normal continence, and intact sensation (measured with somatosensory evoked potentials). The control group underwent laminectomy at 75 days' gestation, but were not repaired. These sheep had the predicted de®cits in motor function and continence.
One of the criticisms of surgical models of myelomeningocele is that the lesion is created much later in gestation than a natural NTD and, as a result, associated central nervous system abnormalities may not be present. However, posterior fossa changes are seen in newborn mice that have surgically created myelomeningocele [40] . These changes are similar to those found in mice with genetic causes of myelomeningocele. Recently, Paek et al. [47 . . ] demonstrated that hindbrain herniation occurs in fetal sheep after surgically created myelomeningocele. After repair, however, the herniation was absent. In this experiment, 20 fetal sheep underwent surgical creation of a myelomeningocele at 75 days' gestation. Four fetuses died after this procedure, and one had spontaneous closure. Of the remaining 15, nine underwent repair at 100 days' gestation. There were two fetal deaths in the repair group, and three in the unrepaired group. On pathological analysis, the seven sheep that survived repair had no evidence of hindbrain herniation whereas the three remaining in the unrepaired group all demonstrated herniation, de®ned as downward displacement of the cerebellar vermis and medulla through the foramen magnum.
Human observation
Experimental evidence supports early closure of the myelomeningocele defect in order to allow for nerve repair [48] . It is postulated that the fetal environment somehow allows for more plasticity in the developing nervous system, and that closure of the defect allows for accelerated repair or regeneration [48] . Axonal regeneration has been demonstrated in developing animals provided that myelination had not occurred [49±51]. Human spinal cord myelination begins around the 15th week of gestation and is well documented by the 20th week [52±56]. It is conceivable that early closure of the myelomeningocele defect allows for more spinal cord regeneration, resulting in a better functional outcome.
Fetal surgery in humans
Ultrasonographic examination of fetuses with myelomeningocele at 18 weeks' gestation demonstated lower limb movements that correlate with those of unaffected fetuses, suggesting that the loss of motor function in these patients occurs later in gestation [57] . Postmortem examination of stillborn human fetuses with myelomeningocele reveals signi®cant normal spinal cord development, with evidence of recent injury to the exposed spinal cord [3]. These results were corroborated in a study of aborted human fetuses with myelomeningocele [58] . Perhaps the most compelling argument for in-utero repair of myelomeningocele comes from observed de®cits in milder forms of spinal dysraphism in which the spinal cord elements remain covered by skin or adipose tissue, e.g. cervical dysraphism, lipomyelomeningocele, or hemimyelomeningocele. These patients tend to have much milder de®cits than those with myelomeningocele [59,60,61 . ].
The development of operating techniques and postoperative care of these patients is evolving at a rapid pace. Currently, fetal surgery for myelomeningocele is performed at three centers: Vanderbilt University Medical Center (VUMC), The Children's Hospital of Philadelphia (CHOP), and The University of California, San Francisco (UCSF). In the review period covered by this article, there have been seven clinical reports regarding myelomeningocele repair in utero and outcome. Those articles and appropriate previous work are reviewed.
Feasibility studies for fetoscopic repair in a sheep model seemed promising [62, 63] . The ®rst attempt at in-utero repair using a fetoscopic technique was in 1994 by Bruner et al. open procedure was the standard dissection and closure with multiple layers. Notably, the fetoscopic group had two fetal deaths with a third delivering prematurely at 28 weeks' gestation. The two survivors in the fetoscopic group both required postnatal reoperation for de®nitive closure, as the skin grafts were not adequate. The patients in the open repair group also experienced complications. One of the mothers suffered a uterine dehiscence at 33 weeks' gestation with herniation of the fetal foot into the peritoneal cavity. Although none of the mothers who underwent fetoscopy experienced serious postoperative contractions, the women who underwent hysterotomy all required secondary admission to the hospital for tocolytic therapy. All six surviving infants in this series demonstrated evidence of the Chiari malformation and four required a ventriculoperitoneal shunt during the reported period of follow-up. The level of neurological impairment in all of the children has been estimated to correlate with the level of the myelomeningocele, indicating no improvement attributable to fetal repair in general.
The ®rst report from CHOP suggested that intrauterine repair of myelomeningocele results in improvements in neurological function and hindbrain herniation and the associated Chiari malformation [65] . In their patient, the myelomeningocele extended from the eleventh thoracic level to the ®rst sacral level. The open technique was performed at 23 weeks' gestation, and a temporary shunt was placed at the site of repair. The child's neurological impairment at birth correlated with an L5 level on the left and L4 on the right, which was better than predicted. Furthermore, postnatal magnetic resonance imaging (MRI) con®rmed the length of the myelomeningocele defect. The MRI also showed no evidence of the Chiari malformation and no hydrocephalus [65] . These ®ndings recapitulate the results of the sheep experiments cited above by Meuli et al. [46] . A possible reason why this patient had a better neurological outcome than the ones described above may be because of the early gestational age at surgery. Unfortunately, subsequent reports have not shown such a dramatic improvement in neurological function [66 . . ].
The technical dif®culty associated with fetoscopic repair has been corroborated by three cases performed fetoscopically by the UCSF Fetal Treatment Group [67] . Although fetoscopy is an attractive modality given that it is`less invasive' to the mother, it is quite technically challenging and cannot currently be performed with as much precision as a standard repair done via a hysterotomy. Despite preterm labor in all mothers undergoing fetal surgery, the mean gestational age at delivery for those undergoing myelomeningocele repair is approximately 34 weeks [66 . . ,68 . . ]. This is several weeks longer than those fetuses who undergo surgery for life-threatening hydrops (e.g. sacrococcygeal teratoma, cystic adenomatoid malformation) and may be due to the fact that, comparatively, fetuses with myelomeningocele are not`sick' and thus tend to stay in the uterus longer. Therefore, at this time, the open technique is advocated for fetal repair of myelomeningocele [64 . . ].
Outcome measures
In an effort to assess function improvement after fetal surgery for MMC, various outcomes have been observed. These include: the rate of hindbrain herniation and need for VP shunting, sensorimotor function, and urinary bladder function.
Hindbrain herniation and the need for ventriculoperitoneal shunting
An unexpected result of fetal surgery for myelomeningocele has been the reduction and sometimes complete reversal of hindbrain herniation. As stated above, the ®rst patient described by the CHOP group demonstrated this phenomenon, and Paek et al. weeks of life. However, other defects associated with the Chiari malformation such as beaking of the tectum and a vertical tentorium were seen in all patients. The improvement in neurological function was approximately one to two levels better than predicted by the level of the lesion; however, this ®nding is also seen in the postnatal repair of myelomeningocele. Complications in this group of patients included four instances of premature delivery with one death attributable to prematurity. Also, one infant required reoperation at one week of life for a CSF leak. At that operation, a tethered spinal cord was noted and was subsequently released. Another child also required a tethered cord release. Finally, one infant needed a ventriculoperitoneal shunt at 2 weeks of life for hydrocephalus. The authors discussed the dif®culty of ®nding a control group for comparison in their study. Although their results demonstrate an improvement in herniation and an increase in the size of the posterior fossa, it can be argued that their selection process for fetal surgery selects`good' candidates who would not have demonstrated herniation with standard treatment. The authors go on to state that it is dif®cult to create an appropriate control group as patients who are not suitable candidates for fetal intervention either go elsewhere to have the procedure performed, or choose to terminate the pregnancy. In any event, those patients who are not candidates for fetal surgery are often not an appropriate control group as a result of other factors such as an abnormal fetal karyotype or other structural abnormalities.
Similarly, at VUMC, Tulipan et al. [69 . . ] studied nine patients undergoing fetal surgery for myelomeningocele, and assessed them for the degree of hindbrain herniation. Preoperative ultrasound scans were compared with postnatal scans in seven patients; two could not return for follow-up scanning. Those patients had postnatal MRI locally. Using a grading system that ranged from zero to six, the degree of hindbrain herniation was assessed. Preoperatively, all patients had evidence of herniation, with a mean grade of 4.3+1.6. Postnatally, three patients had no evidence of herniation, and the mean grade was 0.9+0.9. In their discussion, the authors address some important issues. Allthough once again, it is shown that intrauterine surgery for myelomeningocele improves hindbrain herniation, it is not clear that restoration of the posterior fossa will have any effect on the symptoms associated with the Chiari malformation. Furthermore, the authors state that in the most severely affected patients, symptoms are attributable to disordered circuitry, not mechanical forces [70] . Finally, they mentioned that it is uncertain whether a reduction in hindbrain herniation will translate directly to a reduction in shunt rate, which is the most critical clinical issue related to the Chiari malformation. At VUMC, 21 out of 42 patients required shunting after fetal surgery [69 . . ]. Tulipan et al.
[69 . . ] then postulated that hydrocephalus in myelomeningocele may not be a¯uid mechanics issue but an issue of CSF malabsorption instead.
In a related article, Bruner et al. [68 . . ] compared 29 patients who had undergone fetal repair of myelomeningocele at VUMC to matched historical controls from the same institution to examine the incidence of shuntdependent hydrocephalus. Data collected included the rate of shunt placement and complications. The patients were followed for a minimum of 6 months postpartum. Their results showed a decrease in the shunt rate (59 versus 91%), an increase in the mean age at shunt placement (50 versus 5 days), a decreased incidence of hindbrain herniation (38 versus 95%), and a decreased incidence of clubfoot (28 versus 70%) [68 . . ]. Their data analyses are¯awed because there were no uniform objective criteria for the placement of a ventriculoperitoneal shunt for all patients. Also, their follow-up was too short because, anecdotally, ventriculoperitoneal shunts have been placed into fetal patients as long as 11 months after birth (N.S. Adzick, J.P. Bruner, personal communication). Their maternal complication rate was also signi®cant, with an increased incidence of oligohy-dramnios in the study group (48 versus 4%), increased preterm contractions (50 versus 9%), increased premature rupture of membranes (28 versus 4%), decreased gestational age at delivery (33.2 versus 37.0 weeks), and decreased birthweight (2171 versus 3075 g). Other signi®cant maternal complications included intraoperative placental abruption, maternal small bowel obstruction 5 weeks postoperatively, and uterine scar dehiscence with partial fetal herniation. The last case was previously reported in the authors' ®rst report of three cases of myelomeningocele repair in utero [71]. In their discussion, Bruner et al. [68 . . ] repeated that the reduction in hindbrain herniation seen after fetal surgery for myelomeningocele was an unexpected ®nding, and that the neurological functional status of each patient was no better than predicted by the level of the spinal cord lesion. They also explained that the rate of shunting was dif®cult to control in their patients because they tended to return home (often far away) for postnatal care, and as a result, the decision to shunt was made by the referring institution for each patient. Another phenomenon that may explain the initial decrease in ventriculoperitoneal shunt placement is that parents and physicians treating these patients postnatally have become`shunt averse'. That is, treating physicians have become less liberal in placing shunts because their placement is regarded as a treatment failure. A certain proportion of fetal surgery patients without an immediate life-threatening reason for a ventriculoperitoneal shunt, who would have normally had one in the early neonatal period, are thus having one placed, but at a much later time (months later).
In a follow-up study, Tulipan and colleagues [72 . . ] invited the ®rst 28 patients who had undergone in-utero surgery for myelomeningocele back to VUMC. The patients underwent extensive evaluation over the course of 2 days, which included examination by obstetric, orthopedic, physical therapy, and developmental experts. Plain radiographs, ultrasound examinations and MRI studies were performed. Their results essentially mirror those above. The authors demonstrated an improvement in grading of hindbrain herniation (1.3 study versus 2.6 control), and decreased shunt rate (58 versus 92%). They stated that only two out of 26 (8%) have symptoms attributable to the Chiari malformation, whereas historically, up to 30% of patients with the Chiari malformation become symptomatic. Furthermore, the study group again failed to demonstrate any improvement in neurological function over predicted levels. Finally, the issue of an appropriate control group is raised again as the authors noted that there is an overrepresentation of lower lesions in the study group.
Sensorimotor function
As stated earlier, improvements in sensorimotor function have not been as striking as the suggested improvements in hindbrain herniation and the need for ventriculoperitoneal shunting. The motor and sensory levels of most of the patients studied have been within one or two vertebral levels of the myelomeningocele. These results are similar to those of early postnatal repair in which newborns regain some function one or two levels below the level of the defect [38] .
Urinary bladder function
The presence or absence of urinary continence corresponds well with sensorimotor level, e.g. if the patient demonstrates motor function at the S2±S4 level, he or she has a very good chance of having intact detrusor function [73] . Otherwise, patients with lumbar lesions have lifelong problems with urinary and fecal continence. In the past, patients underwent urinary diversion procedures, but these were poorly tolerated by patients, and stomal complications often led to obstructive nephropathy [74] . Recently, a review of 12 patients with myelomeningocele in their third decade of life, who had not undergone any diversion, demonstrated good preservation of renal function, but poor continence [75] . Their intact renal function was attributed to the aggressive management of infections and to the early institution of clean, intermittent catheterization, not to an improvement in myelomeningocele repair. Only two patients were continent enough to use`light protection' during the daytime, all the others wore diapers.
The investigators at VUMC examined the urological outcomes of 16 patients with myelomeningocele who underwent fetal surgery [76 . . ]. Using urodynamics, they compared the functional outcome of their fetal surgery patients to historical controls. Their results demonstrated no improvement. The authors noted, however, that the mean age of evaluation in the study was 6.5 months of age, thus long-term evaluation will be more representative [76 . . ].
A multicenter, prospective, randomized trial
It is unknown whether or not fetal surgery for myelomeningocele is truly bene®cial compared with term delivery and standard postnatal care. Myelomeningocele is generally not a fatal disease in utero or postnatally, and the majority of prenatally diagnosed infants survive at birth and lead productive lives. Despite this, nearly 200 mothers and fetuses have undergone prenatal surgery for myelomeningocele at VUMC, CHOP, and UCSF. At this point the data, although somewhat encouraging, can only be considered preliminary. The issues of maternal morbidity, fetal morbidity and mortality, and neonatal long-term outcome compared with matched controls need to be scienti®cally addressed. Furthermore, in this age of internet/web site`advertising', it is paramount that we de®ne the role of fetal surgery for myelomeningocele more clearly. Media exposure and internet in¯uence have resulted in an increasing demand for an unproved intervention, and have piqued the interest of other physicians who have begun to establish fetal treatment centers with the hope of treating myelomeningocele prenatally. The resolution of these concerns can occur swiftly and properly with the establishment of a multicenter prospective randomized trial comparing fetal repair at a certain range of gestational age with postnatal care. Group assignments would be random and the counselling, operative techniques, postoperative and neonatal care standardized. There would be objective criteria for the placement of ventriculoperitoneal shunts and objective testing performed to evaluate sensorimotor and anorectal/bladder function. The follow-up would be long term (6 years) and examinations performed at regular intervals by an experienced third party physician. Finally, there would be universal agreement among those performing fetal surgery that no procedures would be performed outside of the trial, therefore eliminating the`back door' issue.
The group at UCSF has recently been funded by the National Institutes of Health to perform a randomized clinical trial on myelomeningocele addressing the aforementioned issues. At present, this single institution trial is being converted to a three center (UCSF, VUMC, CHOP) cooperative trial. This is one of two randomized fetal clinical trials underway at UCSF (the other is on congenital diaphragmatic hernia). The experience gleaned during the randomization process for these trials is that non-directive counselling, which clearly states that we, as physicians, do not know which treatment (postnatal care versus fetal surgery) is most bene®cial, nearly always results in families willing to be randomly selected and subsequently accepting their randomization group. The families most often state that they are relieved that the decision is random and is, for all intents and purposes, taken out of their hands. This is in stark contradistinction to an editorial in the Journal of the American Medical Association that responded to Adzick and Bruner articles [66 . . ,67] regarding myelomeningocele outcomes. The editorial correctly stated that the only way to answer the question of safety and ef®cacy of prenatal therapy for myelomeningocele is through a clinical trial. However, the author went on to state, using a variety of erroneous reasons, that`[an] ideal randomized study of fetal surgery is not possible' [77 . . ].
The role of the prenatal repair of myelomeningocele is presently being established through a randomized controlled clinical trial. It is paramount to study this question scienti®cally now, before it becomes an accepted, but largely unproved therapy with signi®cant maternal morbidity.
